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hospholipase D (PLD) generates lipid signals that
coordinate membrane trafﬁcking with cellular signaling.
PLD activity in vitro and in vivo is dependent on
phosphoinositides with a vicinal 4,5-phosphate pair. Yeast
and mammalian PLDs contain an NH
 
2
 
-terminal pleckstrin
homology (PH) domain that has been speculated to specify
both subcellular localization and regulation of PLD activity
through interaction with phosphatidylinositol 4,5-bisphos-
 
phate (PI[4,5]P
 
2
 
). We report that mutation of the PH domains
of yeast and mammalian PLD enzymes generates catalytically
active PI(4,5)P
 
2
 
-regulated enzymes with impaired biological
functions. Disruption of the PH domain of mammalian
PLD2 results in relocalization of the protein from the
PI(4,5)P
 
2
 
-containing plasma membrane to endosomes. As
a result of this mislocalization, mutations within the PH
P
 
domain render the protein unresponsive to activation in
vivo. Furthermore, the integrity of the PH domain is vital for
yeast PLD function in both meiosis and secretion. Binding of
PLD2 to model membranes is enhanced by acidic phospho-
lipids. Studies with PLD2-derived peptides suggest that this
binding involves a previously identiﬁed polybasic motif
that mediates activation of the enzyme by PI(4,5)P
 
2
 
. By
comparison, the PLD2 PH domain binds PI(4,5)P
 
2
 
 with
lower afﬁnity but sufﬁcient selectivity to function in concert
 
with the polybasic motif to target the protein to PI(4,5)P
 
2
 
-rich
membranes. Phosphoinositides therefore have a dual role
in PLD regulation: membrane targeting mediated by the
PH domain and stimulation of catalysis mediated by the
polybasic motif.
 
Introduction
 
Phospholipase D (PLD)* hydrolyzes phosphatidylcholine
(PC) to form phosphatidic acid. In mammalian cells, PLD
activity is under tight control by cell surface receptors acting
through pathways involving GTP-binding proteins and protein
kinases. Recent studies identify multiple roles for PLD at the
interface between cell signaling and membrane trafficking
(Liscovitch et al., 2000). In budding yeast, genetic approaches
have identified a conditional role for PLD (the product of
the 
 
SPO14
 
 gene) in secretion and an obligatory role in
sporulation, wherein PLD activity is required for formation
of the prospore membrane (Rudge and Engebrecht, 1999).
Targeting PLDs to different sites within the cell is vital
for their functions. The mammalian PLD enzymes, PLD1
and PLD2, exhibit cell-specific differences in subcellular local-
ization. PLD2 is generally found in the plasma membrane
and, in some cases, endosomes (Colley et al., 1997; Honda
et al., 1999), whereas PLD1 has been reported to localize to
the Golgi apparatus, endosomes, lysosomes, and plasma
 
membrane as well as more specialized vesicles such as histamine
granules in mast cells and glut4-containing vesicles in adipo-
cytes (Brown et al., 1998; Emoto et al., 2000; Freyberg
et al., 2001). In budding yeast, Spo14p moves from a de-
tergent-insoluble membrane compartment in vegetatively
growing cells to the prospore membrane during meiosis
(Rudge et al., 1998a).
The mechanisms responsible for targeting PLD enzymes
to different cellular membranes are poorly understood. PLD
enzymes contain domains with proven or potential roles in
protein–protein and protein–lipid interactions that are likely
involved in this process. All PLD enzymes share a common
catalytic core composed of a duplicated “HKD” motif,
which constitutes the essential enzymatic machinery flanked
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by two additional PLD-specific domains (Hammond et al.,
1995). Yeast and mammalian PLDs are potently and spe-
cifically activated by phosphatidylinositol 4,5-bisphosphate
(PI[4,5]P
 
2
 
) (Brown et al., 1993; Rose et al., 1995). This
stimulation is mediated by a polybasic amino acid sequence
within the catalytic core. Although mutation of this region
does not affect the subcellular localization of PLD2 or
Spo14p, mutant alleles of these enzymes with reduced re-
sponsiveness to PI(4,5)P
 
2
 
 are nonfunctional in a number of
settings (Sciorra et al., 1999, 2001; Vitale et al., 2001). The
NH
 
2
 
 terminus of the yeast and mammalian PLDs contains
Phox and pleckstrin homology (PX and PH) domains.
These domains are found in a wide variety of proteins and
bind phosphoinositides with varying selectivities and affini-
ties. Although clearly dispensable for stimulation of catalysis
by PI(4,5)P
 
2
 
, this NH
 
2
 
-terminal region plays a role in both
regulation of PLD activity and, in the case of PLD1, local-
ization to the plasma membrane (Sugars et al., 1999; Sung et
al., 1999a,b; Hodgkin et al., 2000; Sciorra et al., 2001).
Here we identify potential phosphoinositide-interacting
amino acid residues within the PH domains of PLD2 and
Spo14p. Mutation of these residues does not affect the intrinsic
catalytic activity of either enzyme but renders them nonfunc-
tional in a number of settings, which arises from changes in the
distribution of the enzymes between different intracellular
membrane compartments. In this study, we show that weak,
but highly selective, binding of the PLD2 PH domain to
PI(4,5)P
 
2
 
 underlies the requirement of this domain for PLD
localization and function and suggest that the PH domain
works in combination with the polybasic motif to target these
proteins to PI(4,5)P
 
2
 
-rich membrane structures. This targeting
is vital for PLD function in yeast and mammalian cells.
 
Results
 
Sequence comparisons of PLD PH domains
 
Fig. 1 shows the primary structure of the yeast and mamma-
lian PLD enzymes highlighting the catalytic core (regions I,
II, III, and IV), the NH
 
2
 
-terminal PX and PH domains, and
the polybasic motif that encompasses conserved residues that
have been previously shown to be vital for binding to phos-
phoinositides and activation of the enzymes by these lipids.
Structural and biophysical studies reveal that PH domains
vary widely in their affinities for phosphoinositides (for re-
view see Lemmon and Ferguson, 2000). Although the over-
all three-dimensional structure of PH domains is highly con-
served, there is strikingly little homology at the primary
sequence level. Sequence comparisons of the PH domains of
the PLD enzymes with regions of PH domains that bind
PI(4,5)P
 
2
 
, such as PLC-
 
 
 
1
 
, spectrin, and Btk, determined in
complex with their ligands, identified tandem basic amino
acids within the variable “loop” connecting 
 
 
 
-strands 3 and
4 that could participate in electrostatic interactions with the
phosphate groups of phosphoinositides. In PLD2, these cor-
respond to residues K236 and R237 and in PLD1 to resi-
dues K252 and K253. Spo14p has a single lysine (K533) in
the cognate sequence at a position that corresponds to the
second basic residue in the mammalian PLD sequence. We
also identified a conserved tryptophan residue adjacent to
R237, W238, that, again by comparison with structures of
other phosphoinositide-binding PH domains, could partici-
pate in hydrogen bonding interactions with the inositol ring.
 
An intact PH domain is required for activation of PLD2
 
To evaluate the effect of PH domain disruption on PLD2
function and localization in cells, we generated a PLD2 mu-
tant in which potential phosphoinositide-interacting resi-
dues R237 and W238 were substituted with glycine in a vec-
tor for expression of PLD2 with an NH
 
2
 
-terminal GFP tag.
GFP–PLD2 R237G/W238G and GFP-tagged variants of
wild-type PLD2 and a catalytically inactive PLD2 mutant
(PLD2 K578R) were expressed in HEK 293 cells by tran-
sient transfection. The recombinant proteins were immuno-
precipitated using an anti-GFP antibody and probed by
Western blotting. Each construct produced a protein of the
expected size and expression levels were comparable for all
Figure 1. Domain structure of yeast 
and mammalian PLD enzymes. Linear 
representations of the primary sequences 
of PLD1, PLD2, and Spo14p are shown 
noting the four conserved catalytic 
domains (regions I through IV), the PX and 
PH domains, and the polybasic region. 
Sequence comparisons of these latter 
two domains are shown in detail high-
lighting conserved amino acid residues 
and sequences targeted for mutation. 
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three proteins. The PLD activity associated with these im-
mune complexes was determined in vitro using sonicated
phospholipid dispersions. Although PLD2K578R was inac-
tive in these assays, the PH domain PLD2 mutant had an in
vitro activity that was comparable to that of wild-type PLD2
(Fig. 2 A). Activity of both wild-type PLD2 and PLD2
R237G/W238G was strongly dependent on inclusion of
PI(4,5)P
 
2
 
 in these substrate preparations (unpublished data),
underscoring our previous finding that the PH domain plays
no role in the stimulation of catalysis by phosphoinositides
(Sciorra et al., 1999). In contrast to these in vitro assay re-
sults, when PLD activity was measured in cells using a
transphosphatidylation assay against radiolabeled cellular
substrates, only wild-type PLD2 showed significant in-
creases in activity in response to two known pharmacological
activators, PMA and A23187 (Fig. 2 B). Activity of the PH
domain mutant was indistinguishable from that of the cata-
lytically inactive PLD mutant. Although the PH domain
mutant is expressed at slightly lower levels than wild type
(unpublished data; Fig. 3 A), it maintains in vitro activity
similar to wild type, so modestly lower expression levels can-
not account for these findings. As discussed below, we have
expressed PLD2 R237G/W238G in insect cells using a bac-
ulovirus vector and found that the activity of this PLD2 mu-
tant and its response to stimulation by PI(4,5)P
 
2
 
 are identi-
cal to what we previously reported for wild-type PLD2.
These findings show that the PH domain is dispensable for
PLD activity against substrates presented in vitro but is criti-
cal for the expression of enzyme activity in a cellular setting,
at least under conditions where the cells were treated with
two pharmacological agents that increase PLD activity.
 
Localization of PLD2 to detergent-resistant membrane 
microdomains requires an intact PH domain
 
One explanation for the inactivity of PLD2 R237G/W238G
in vivo is that the mutant enzyme may not be localized cor-
rectly to interact with appropriate activators and/or respond
to external stimuli. We therefore first examined the distribu-
tion of wild-type and PH domain mutant PLD2 between
soluble and total membrane fractions in transiently trans-
fected HEK 293 cells. Both the PH domain mutant and the
catalytically inactive mutant distributed almost exclusively
to the membrane fraction, similar to the wild-type protein
(Fig. 3 A). PLD2 partially localizes to detergent-resistant
Figure 2. An intact PH domain is required for activation of PLD in 
HEK 293 cells. (A) PLD was immunoprecipitated from HEK 293 cells 
transiently transfected with pEGFP vector or with pEGFP constructs 
harboring wild-type PLD2, PLD2 K758R, or PLD2 R237G/W238G 
using anti-GFP antibody. Activity in the immunoprecipitates (IP) was 
determined and normalized to equivalent protein amounts determined 
from corresponding IP by Western blotting. (B) HEK 293 cells were 
transfected with pEGFP vector or with pEGFP constructs harboring 
wild-type PLD2, PLD2 K758R, or PLD2 R237G/W238G. The cells 
were labeled with [
3H]palmitic acid and PLD activity was determined 
by measuring the formation of [
3H]phosphatidylbutanol. Incubations 
contained vehicle (white bars), 100 nM PMA (gray bars), or 19
 M A23187 (black bars) for 30 min at 37 C. The data shown are 
means   SD of triplicate determinations. Similar results were
obtained in two additional experiments.
Figure 3. Localization of PLD to detergent-resistant membrane 
microdomains requires an intact PH domain. (A) Immunoblot of 
particulate (P) and supernatant (S) fractions prepared from HEK 293 
cells transfected with pEGFP vector or with pEGFP constructs 
harboring wild-type PLD2, PLD2 K758R, or PLD2 R237G/W238G. 
(B) HEK 293 cells expressing HA-tagged wild-type PLD2, PLD2 
R554G/R558G, or PLD2 R237G/W238G were lysed in 1% Triton 
X-100 and fractionated on a sucrose density gradient. 1-ml aliquots 
were collected with fraction 1 representing the top of the gradient 
and fraction 12 the bottom. Protein patterns in 1/30 of each fraction 
were analyzed for the indicated protein by Western blotting using 
anti-HA antibody. 
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membrane microdomains, a specialized domain of the
plasma membrane (Sciorra and Morris, 1999). Because these
putative domains are speculated to localize many types of
signaling molecules, it has been suggested that they provide
a proper physiological environment for the activation of
PLD2 in a cellular setting (Sciorra and Morris, 1999; Fiucci
et al., 2000). We examined the localization of wild-type
PLD2 and PLD2 R237G/W238G to detergent-resistant
membrane domains by fractionating detergent lysates from
HEK293 cells that had been transfected with constructs for
expression of these proteins. Wild-type PLD2 was recovered
in both detergent-soluble and detergent-resistant fractions,
whereas PLD2 R237G/W238G was only detected in the de-
tergent-soluble fraction (Fig. 3 B). These results suggest that
a functional PH domain is required for the localization of
PLD2 to detergent-resistant membrane microdomains, and
that localization to these domains may be critical for PLD2
activation in cells under certain settings.
 
The PH domain determines localization of PLD2 
to the plasma membrane
 
We used laser scanning confocal microscopy to examine the
subcellular localization of wild type and the PH domain mu-
tant PLD2 R237G/W238G in HEK293 and HeLa cells.
Whereas GFP alone shows a typically cytosolic and partially
nuclear distribution in both cells, in HEK293 cells, wild-type
 
GFP–PLD2 was almost exclusively plasma membrane localized
with some punctate staining throughout the cytoplasm (Fig. 4,
A, B, and D). The localization of wild-type GFP–PLD2 (Fig. 4
E) or of a catalytically inactive PLD2 mutant in HeLa cells (un-
published data) was overtly similar to that in HEK293 cells, ex-
cept that in HeLa cells, the protein was more evenly distributed
between the plasma membrane and small punctate structures
within the cytoplasm. By contrast, in both HEK293 cells and
HeLa cells, the PLD2 PH domain mutant PLD2 R237G/
W238G was not localized to the plasma membrane and was ex-
clusively found within small punctate structures within the cy-
toplasm (Fig. 4, C and F). These punctate structures most likely
are early endosomes, because we see considerable colocalization
of the PH domain mutant with an early endosome marker,
EEA1, in HEK293 cells (Fig. 4, G–I). The failure of GFP–
PLD2 R237G/W238G to localize to detergent-resistant micro-
domains is likely due to this redistribution to an intracellular
membrane compartment. Integrity of the PH domain of PLD2
is therefore required for localization to the plasma membrane,
where the enzyme is responsive to stimulation.
 
The PH domain of Spo14p is dispensable for stimulation 
of PLD activity by PI(4,5)P
 
2
 
 but is required for cellular 
function in 
 
Saccharomyces cerevisiae
 
Budding yeast contain a single PLD enzyme encoded by the
 
SPO14
 
 gene (Rose et al., 1995). Proper localization and acti-
Figure 4. Effect of PH domain mutations 
on subcellular localization of PLD2. HEK 
293 cells (A–C and G–I) or HeLa cells 
(D–F) were grown on coverslips and tran-
siently transfected with pEGFP (A and D), 
pEGFP-PLD2 (B and E), or pEGFP-PLD2 
R237G/W238G (C and F–I). The distri-
bution of the expressed GFP-tagged 
proteins and markers was examined by 
laser scanning confocal microscopy. The 
series of images (G–I) are from cells 
that were stained with antibody against 
the early endosome marker EEA1 
detected using a rhodamine-conjugated 
secondary antibody. 
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vation of Spo14p is required for sporulation, where it func-
tions in a developmentally regulated secretory pathway that
controls the formation of the prospore membrane (Rudge et
al., 1998a,b). Spo14p also plays a conditional role in the main-
tenance of a functional secretory pathway required for permis-
sive actions of a set of genes under conditions where function
of the Sec14 lipid transfer protein has been ablated (Sreenivas
et al., 1998; Xie et al., 1998; Rudge et al., 2001). We therefore
examined effects of mutating the Spo14 PH domain on activ-
ity and function of the PLD enzyme under these two physio-
logical settings. The first conserved K residue at position 533
in Spo14p, which is analogous to the R residue in the PLD2
R237G/W238G mutant, was mutated to E. HA–Spo14p and
HA–spo14
 
K533E
 
p were expressed under the control of the en-
dogenous promoter in homozygous 
 
spo14
 
 diploids and in-
duced to sporulate. Immunoprecipitated proteins were then
assayed for PLD activity in response to PI(4,5)P
 
2
 
. As shown in
Fig. 5 A, the activity of spo14
 
K533E
 
p was stimulated by
PI(4,5)P
 
2
 
 to a similar degree as Spo14p. These results are in
agreement with those obtained with the mammalian PLD en-
zymes and indicate that the integrity of the PH domain is not
required for PI(4,5)P
 
2
 
-stimulated activity of yeast PLD.
We next evaluated the ability of 
 
spo14-K533E
 
 to comple-
ment the sporulation defect of homozygous 
 
spo14
 
 diploids.
Whereas 
 
SPO14
 
 efficiently restored sporulation when ex-
pressed from a CEN plasmid (
 
 
 
65% spores), 
 
spo14-K533E
 
only poorly rescued the sporulation defect (
 
 
 
5% spores;
Fig. 5 B). Sporulation was not improved when the mutant
was expressed at higher levels by using a 2 micron plasmid,
indicating that the failure to complement was not due to ex-
pression levels (Fig. 5 B). spo14
 
K533E
 
p behaved similarly to
the wild-type protein with respect to its fractionation prop-
erties, both being particulate in nature (Fig. 5 D), indicating
that the protein was not grossly altered by this mutation.
Thus, an intact PH domain is required for the in vivo func-
tion of yeast PLD in meiosis.
We also tested the ability of spo14
 
K533E
 
p to restore cell
growth in a 
 
sec14
 
 bypass mutant deleted for 
 
SPO14
 
 (
 
sec14-1
 
,
 
kes1
 
,
 
 spo14
 
). HA–Spo14 effectively supported growth at a
temperature that was nonpermissive for 
 
sec14-1
 
 function
(Fig. 5 C). However, 
 
spo14-K533E
 
 only partially comple-
mented the 
 
sec14
 
 bypass phenotype when expressed from a
centromere plasmid. In contrast to what was observed dur-
ing sporulation, when expressed from a 2 micron plasmid,
spo14
 
K533E
 
 supported wild-type growth (Fig. 5 C). The abil-
ity of 
 
spo14-K533E
 
 to support 
 
sec14
 
 bypass when expressed
from a high copy number plasmid indicates that the PH do-
main does not play as critical a role during vegetative Sec14-
independent growth as it does during sporulation. Never-
theless mutation of the PH domain of Spo14 results in a
catalytically competent PI(4,5)P
 
2
 
-responsive PLD, which is
not fully functional in vivo.
 
The PLD2 PH domain binds to PI(4,5)P
 
2
 
 
with low affinity but high selectivity
 
The studies described above identify a critical role of the PH
domain in the localization and function of PLD2 and
Spo14p and suggest that this involves interactions with
PI(4,5)P
 
2
 
. To test this idea directly, the PLD2 PH domain
was expressed in insect cells using a baculovirus vector and
purified by immunoaffinity chromatography. The protein
was incubated with varying concentrations of sucrose-loaded
large unilamellar phospholipid vesicles (LUVs) composed of
PC or PC plus a 5% molar fraction of PI(4,5)P
 
2
 
. The vesi-
cles were sedimented by ultracentrifugation and vesicle-
bound protein was detected by Western blotting. The PLD2
PH domain did not bind appreciably to PC vesicles at lower
lipid concentrations and bound weakly at the highest con-
centration examined (10
 
 
 
3
 
 M total lipid). By contrast, inclu-
sion of PI(4,5)P
 
2
 
 in these vesicles resulted in significant
binding of the PLD2 PH domain that could be detected at a
lower total lipid concentration of 3 
 
 
 
 10
 
 
 
5
 
 M. Quantitation
of immunoreactive protein on these Western blots by scan-
ning densitometry revealed that the recovery of PLD2 PH
domain protein in the vesicle-bound fraction at the highest
concentration examined was 
 
 
 
80% of protein input and
Figure 5. Analysis of PH domain 
function in Spo14p. (A) PLD activity of 
immunoprecipitates of yeast harboring 
HA-Spo14 CEN (Wt) and HA-Spo14-
K533E CEN (K E) as described in Rudge 
et al. (1998a) and Sciorra et al. (1999). 
PLD activity was measured using 50  M 
BODIPY-PC in the presence (dark gray) 
or absence (light gray) of PI(4,5)P2. Inset, 
Western blot of the immunoprecipitated 
proteins. (B) Sporulation efficiencies of 
yeast harboring HA–Spo14 CEN (Wt), 
HA–Spo14-K533E CEN (K E CEN), 
and HA–Spo14-K533E 2  (K E 2 ). 
(C) Complementation analysis of spo14 
deletion, sec14 bypass mutant phenotype 
(no growth at 37 C) with HA–spo14-
K533E CEN (K E CEN), and HA–spo14-
K533E 2  (K E 2 ). (D) Immunoblot of 
particulate (P) and supernatant (S) fractions 
(equal volumes not equal protein) pre-
pared from yeast harboring HA–Spo14 
CEN (Wt) and HA–Spo14-K533E CEN as 
described in Rudge et al. (1998b).1044 The Journal of Cell Biology | Volume 159, Number 6, 2002
suggested that binding of the PLD2 PH domain was half
maximal at a concentration in the range of 1–3   10
 4 M
total lipid (Fig. 6 A). To examine the phospholipid selectiv-
ity of this association, we determined binding of the PLD2
PH domain to LUVs composed of PC or PC containing
a 5% molar fraction of PI(4,5)P2, phosphatidylinositol
4-phosphate (PI4P), PI, phosphatidic acid, or phosphati-
dylserine (PS). At a fixed total lipid concentration of 3  
10
 4 M, association of the PLD2 PH domain with
PI(4,5)P2-containing LUVs was dramatically greater than
that seen with PC vesicles. In comparison to PC LUVs,
binding could be detected when each of the acidic lipids was
included in the vesicles. This nonspecific binding enhance-
ment has been observed for several different PH domains
and likely reflects the characteristic electrostatic polarization
of this motif, which produces a net positive charge on the
entire membrane binding surface. Using scanning densitom-
etry to quantitate immunoreactive vesicle-bound proteins
revealed that binding of the PLD2 PH domain to PI(4,5)P2-
containing vesicles was  10-fold greater than that seen with
any of the other lipids tested (Fig. 6 B). These results show
that binding of the PLD2 PH domain to model membranes
is significantly and selectively enhanced by PI(4,5)P2. Al-
though the PLD2 PH domain binds to PI(4,5)P2 in these
membranes with high selectivity, the affinity of this interac-
tion is 10–30-fold lower than that shown by the PH domain
of PLC-  when measured under similar conditions (Lem-
mon and Ferguson, 2000). The high affinity and selectivity
of the PLC-  PH domain for PI(4,5)P2 results in the local-
ization of the protein to the plasma membrane in many cell
types. We used laser scanning confocal microscopy to com-
pare the localization of the PLC-  PH domain to that of the
PLD2 PH domain when both proteins were expressed in
HEK293 cells with GFP fused to the NH2 terminus. The
GFP-tagged PLC-  PH domain showed a characteristic
plasma membrane localization. The GFP-tagged PLD2 PH
domain was efficiently expressed and produced an immu-
noreactive protein of the expected molecular weight. In con-
trast to what was observed with the GFP–PLC-  PH do-
main but consistent with results obtained with GFP–PLD2
R237G/W238G (Fig. 4, C and F), the GFP–PLD2 PH do-
main was diffusely localized within the cell (Fig. 6, C–E).
Role of the polybasic domain in membrane 
binding of PLD2
The data presented above show that, when attached to the
rest of the PLD protein, the PLD2 PH domain specifies
plasma membrane localization and that this function most
likely involves association with PI(4,5)P2. Because the in-
trinsic affinity of the PLD2 PH domain for PI(4,5)P2 is in-
sufficient to target the protein to the plasma membrane, we
speculated that other determinants within the PLD2 se-
quence must contribute significantly to the overall affinity of
the protein for cellular membranes. We previously identified
a sequence rich in basic and aromatic amino acid residues
within the catalytic core that is required for activation of
PLD2 and Spo14p by PI(4,5)P2 (Sciorra et al., 1999). This
polybasic domain contains six arginine, lysine, or histidine
residues that are conserved between PLD1, PLD2, and
Spo14p. Substitution of charged residues throughout this
domain that include R554, R558, and R563 produces
PLD2 enzymes that display significantly attenuated stimula-
tion by PI(4,5)P2 (Sciorra et al., 1999; unpublished results).
We found that binding of wild-type PLD2 to LUVs com-
posed of PC/PS/PE, molar ratio 1:1:1 containing a 5% mo-
lar fraction of PI(4,5)P2, was half maximal at a total lipid
concentration of  10
 5 M (Sciorra et al., 1999). We re-
peated these measurements using purified PLD2 R237G/
Figure 6. The PLD2 PH domain binds 
to PI(4,5)P2 with weak affinity but high 
selectivity. (A) Purified PLD2 PH 
domain was incubated with sucrose-
loaded LUVs composed of PC or PC 
containing 5% PI(4,5)P2. Incubations 
contained the indicated total lipid 
concentrations and the LUVs were 
sedimented by ultracentrifugation. 
Vesicle-bound protein was detected 
by Western blotting using an antibody 
against the NH2-terminal glu-glu tag. 
(B) Purified PLD2 PH domain was 
incubated with sucrose-loaded LUVs 
with the indicated phospholipid compo-
sitions at a total lipid concentration of
3   10
 4 M. The LUVs were sedimented 
by ultracentrifugation and vesicle-bound 
protein was detected by Western blotting 
using an antibody against the NH2-
terminal glu-glu tag. These are represen-
tative experiments from several that gave 
similar results. (C) GFP–PLC-  PH domain 
was expressed in HEK293 cells by tran-
sient transfection and its localization 
examined by laser scanning confocal microscopy. (D) GFP–PLD2 PH domain was expressed in HEK293 cells by transient transfection and its 
localization examined by laser scanning confocal microscopy. (E) Proteins from HEK293 cells expressing GFP or GFP–PLD2 PH domain were 
separated by SDS-PAGE and probed by Western blotting using an anti-GFP antibody. Regulation of phospholipase D by phosphoinositides | Sciorra et al. 1045
W238G and another PLD2 mutant in which the invariant
tryptophan residue that lies in the center of the COOH-ter-
minal  -helix of all PH domains was substituted with G
(PLD2 R308G). Both of these PLD2 mutants were stimu-
lated by PI(4,5)P2 to the same extent and with the same con-
centration dependence as wild-type PLD2 (unpublished
data). Both of these mutants also bound to LUVs composed
of PC/PS/PE, molar ratio 1:1:1 containing a 5% molar frac-
tion of PI(4,5)P2, with approximately the same affinity
shown by wild-type PLD2 (unpublished data). These results
are consistent with the relatively weak PI(4,5)P2 binding af-
finity shown by the isolated PH domain.
Substitution of basic amino acids within the polybasic do-
main reduced binding of PLD2 to acidic phospholipids, in-
cluding PI(4,5)P2, suggesting a general role in membrane as-
sociation (Sciorra et al., 1999). We have been unable to
express this domain independently, most likely because of its
proximity to the catalytic core of the enzymes. In an attempt
to determine the contribution of this polybasic region to
membrane binding by PLD2, we synthesized a peptide cor-
responding to the entire sequence. This PLD2-derived pep-
tide has a net charge of  6 and has four aromatic residues
(Fig. 1). We measured the binding of [
3H]PLD2(554–575)
to PC, PC/PS, and PC/PI(4,5)P2 vesicles using the centrifu-
gation technique. Fig. 7 A shows that the PLD peptide binds
weakly to PC vesicles, but with significant affinity to both
PC/PI(4,5)P2 (99:1) and PC/PS (5:1) vesicles. Its binding to
PC/PI(4,5)P2 vesicles (molar partition coefficient K   10
4
M
 1) is similar to the binding of Lys10 (K   3   10
4 M
 1),
but is significantly stronger than that of Lys7 (K   8   10
2
M
 1), which suggests that both the basic and aromatic resi-
dues contribute to the binding (Wang et al., 2002).
We next asked if the peptide could electrostatically seques-
ter PI(4,5)P2 in a membrane that contained a physiological
30-fold excess of monovalent acidic lipid. We monitored the
interaction of PLD2(554–575) with PI(4,5)P2 by using a
PLC assay in a monolayer containing 66:33:1 PC, PS, and
PI(4,5)P2. As shown in Fig. 7 B, PLC hydrolyzes PI(4,5)P2
at a moderate rate in the absence of PLD peptide. With the
addition of 10  M PLD2(554–575), the initial rate of
PI(4,5)P2 hydrolysis decreased  10-fold. Similar inhibitions
were also seen in a previous study with other peptides con-
taining basic and aromatic residues. The simplest explana-
tion is that basic peptides sequester PI(4,5)P2 by means of
nonspecific local electrostatic interactions (McLaughlin et
al., 2002).
Discussion
The broad goal of the work described here was to evaluate
the significance of the NH2-terminal PH domain in the
function of yeast and mammalian PLD enzymes. We were
interested in testing the hypothesis that this region of the
proteins is involved in specific interactions with phospho-
inositides and that the interplay between the PH domain
and a previously described polybasic motif could be critical
for regulating the association of these proteins with cellular
membranes and in the control of PLD activity. Our results
demonstrate that the integrity of the PH domain is required
for proper function of mammalian and yeast PLD. We show
that the PLD2 PH domain binds PI(4,5)P2 with high selec-
tivity but relatively low affinity. Although this affinity is by
itself insufficient to target the protein to the plasma mem-
brane, we identify a role for the internal polybasic motif as a
higher affinity but less selective membrane anchor for these
enzymes. Our data suggest a model in which the polybasic
motif serves as a general membrane anchor for the enzymes,
allowing the PH domain to specify a targeting function that
selectively localizes the enzymes to sites enriched in its
ligand PI(4,5)P2. Because the polybasic motif also serves a
critical function in regulation of the catalytic activity of
these enzymes by PI(4,5)P2, our results identify a dual role
for phosphoinositides in the regulation of PLD function.
The use of combinatorial mechanisms for membrane tether-
ing and localization is a common theme in proteins involved
in many aspects of cell regulation. Our proposal for the
PLD enzymes is conceptually similar to the situation where,
for example, both fatty acylation and electrostatic interac-
tions with phospholipid head groups work together to drive
the membrane association observed with the Src tyrosine ki-
nase and a number of extrinsic membrane proteins (for re-
view see McLaughlin et al., 2002). A similar “regulated
avidity” mechanism has also been proposed for members of
a broad class of PH domains that bind phosphoinositides
with weak affinity but that are capable of oligomerization
(Lemmon and Ferguson, 2000). This mechanism may be
involved in the regulation of the PH domain–containing
protein dynamin during receptor-mediated endocytosis. In
general, PH domains that bind phosphoinositides with af-
finities that are low in comparison to those displayed by the
PH domains from PLC- 1 or spectrin have been reported to
show broad specificity for their ligands (Lemmon and Fer-
Figure 7. Binding and sequestration of PI(4,5)P2 by PLD2 554–575 
peptide. (A) Binding of 
3H-PLD2(554–575) to 99:1 PC/PIP2 ( ), 5:1 
PC/PS ( ), and PC ( ) LUVs was measured by centrifugation. The 
curves are the least square fits of Equation 1 to the data and are from 
three independent experiments. (B) A monolayer containing 66:33:
1 PC/PS/[
3H]PI(4,5)P2 was formed on the surface of 100 mM KCl 
buffer containing PLC-  and peptides. After the addition of PLD 
peptide and PLC-  to the subphase, PLC activity was determined by 
measuring PI(4,5)P2 hydrolysis in the absence of peptide ( ) or in 
the pesence of 5  M ( ) or 10  M ( ) PLD2 554–575 peptide. The 
data are representative of two sets of experiments. The lines show 
linear fits to the data obtained in the first 5 min.1046 The Journal of Cell Biology | Volume 159, Number 6, 2002
guson, 2000). Our results suggest that the PLD2 PH do-
main belongs to a unique class of PH domains with rela-
tively weak, but selective, affinity for PI(4,5)P2. Structural
characterization of this domain will be required to under-
stand the basis of this interaction.
Clearly, protein–lipid interactions are not the only deter-
minants of the subcellular localization of the PLD enzymes.
In the case of PLD2, we found that in comparison to the
wild-type enzyme, mutation of the PH domain resulted in
redistribution from the plasma membrane to an intracellular
membrane compartment, most likely early endosomes. Be-
cause the PH domain mutants of PLD2 are catalytically
competent but are uncoupled from activation by stimuli, we
suggest that this redistribution results in the movement of
PLD2 from a cellular compartment where it is active (the
plasma membrane) to a site where it becomes refractory to
stimulation. The physiological relevance of this observation
is not yet clear, but it is possible that modulation of the
PI(4,5)P2 binding affinity of the PH domain through, for
example, protein phosphorylation could control sorting de-
cisions that dictate retention of the protein in the plasma
membrane or release to the endosomal pathway. The PH
domain–independent mechanism responsible for localizing
PLD2 to endosomes is presently unclear. PX domains con-
trol protein targeting to endosomes through interactions
with phosphatidylinositol 3-phosphate (PI3P) (Sato et al.,
2001), so the PLD PX domain would be a likely candidate
to mediate this interaction. However, we find that several
mutations of the PX domain do not affect the endosomal lo-
calization of PLD2 (unpublished data).
Although we do not know if the PX domain of PLD2
binds PI3P, this domain may be functionally relevant in
other PLD enzymes. PLD1 can apparently bind PI3P in
vitro (Hodgkin et al., 2000), and the PX domain of Spo14p
can bind PI3P in a dot blot assay with low affinity (Yu and
Lemmon, 2001). Substitution of residues within the PX do-
main of Spo14p, which would be expected to ablate PI3P
binding, produces a protein that is nonfunctional in meiosis
and sec14 bypass when expressed from a centromere plasmid,
and although increased gene dosage of this mutant fails to
improve sec14 bypass, it does improve sporulation (unpub-
lished data). This suggests that sec14 bypass and sporulation
are differentially sensitive to the loss of functional PX and
PH domains, which may in turn relate to their likely roles in
controlling subcellular localization of the protein. During
sec14 bypass, Spo14 is found in endosomes (Li et al., 2000),
which are rich in PI3P. In contrast, during sporulation,
Spo14 is relocalized to the developing prospore membrane,
which is rich in PI(4,5)P2 (unpublished data). Although a
distinct NH2-terminal domain is essential for Spo14p local-
ization (Rudge et al., 2002) and mutation of the PH and PX
domains does not grossly alter the localization of the enzyme
to the prospore membrane (unpublished data), it is likely
that these domains both contribute to association of Spo14p
to different cellular membranes, which may include endo-
somes, which are both rich in PI3P and contain an active
pool of Spo14p (Li et al., 2000; Rudge et al., 2001).
Although our results suggest that the PH domains of
PLD2 and Spo14 p are functionally analogous, the role of
the PH domain in the regulation of PLD1 is likely to be dif-
ferent. As with PLD2 and Spo14p, the PH domain of PLD1
is dispensable for stimulation of catalysis by PI(4,5)P2 (Sung
et al., 1999a,b; Sciorra et al., 2001). The PH domain of
PLD1 also contains amino acid residues in analogous posi-
tions to those we suggest are important for PI(4,5)P2 bind-
ing. However, other work has identified tandem cysteine
residues within this domain that are palmitoylated and
would, based solely on energetic considerations, be sufficient
to anchor the protein to membranes independently from in-
teractions with PI(4,5)P2 (Sugars et al., 1999). Murine
PLD2 used in our studies contains a single cysteine residue
at this position, and whereas we can readily detect incorpo-
ration of palmitate into human PLD1 protein after radiola-
beling of transfected HEK293 cells, murine PLD2 is not la-
beled (unpublished data). Spo14p does not contain cysteine
residues in this region, so palmitoylation is unlikely to be an
important posttranslational modification of this protein.
Furthermore, PLD1 is regulated by ARF and Rho family
GTP-binding proteins and certain conventional protein ki-
nase C enzymes, which are themselves membrane associated,
and it is likely that interactions with these proteins also con-
tribute to the membrane targeting of this PLD enzyme. Ge-
netic, biochemical, and biophysical evidence indicates that
these families of proteins are not direct regulators of Spo14p
or PLD2 (Rudge et al., 1998b; Liscovitch et al., 2000; un-
published data). The role of the PH domain in membrane
localization of PLD1 therefore clearly differs from what we
report here for PLD2 and Spo14p.
Our previous work identified a region proximal to cata-
lytic region III of all phosphoinositide-dependent PLD en-
zymes that contains a conserved region of basic and aromatic
amino acid residues. Integrity of this polybasic is required
for interaction with, and activation by, PI(4,5)P2. This re-
gion encompasses seven basic lysine and arginine residues
and mutational studies suggest involvement of the entire re-
gion in phosphoinositide binding and activation of the en-
zymes (Sciorra et al., 1999). Here we show that a peptide
corresponding to the polybasic motif of PLD2 binds to
LUVs containing PI(4,5)P2 with a similar affinity to the in-
tact protein. Detailed studies with this and other small un-
structured basic/aromatic peptides suggest a model for the
peptide–membrane interaction in which the basic amino
acid residues interact through nonspecific, but local, electro-
static interactions with polyvalent acidic lipids such as
PI(4,5)P2, and the aromatic residues penetrate the mem-
brane bilayer to contribute additional hydrophobic binding
energy (for review see McLaughlin et al., 2002). The obser-
vation that this PLD peptide and other basic and basic/aro-
matic peptides exhibit similar binding to both PC/PI(4,5)P2
(99:1) and PC/PS (5:1) vesicles is consistent with a model in
which the local electrostatic potential produced by one mul-
tivalent PI(4,5)P2 (or more than one PI[4,5]P2 in the case of
peptides with 10 or 13 basic residues) is similar to that pro-
duced by 17% PS in the PC/PS bilayer (Wang et al., 2002).
The stoichiometry of the interaction between PI(4,5)P2 and
the polybasic region has not been determined directly, but
clearly at least one and possibly two molecules can bind. The
polybasic peptide can also produce a lateral sequestration of
PI(4,5)P2 in a model membrane that contains an excess of a
monovalent acidic lipid. Although stimulation of catalysis Regulation of phospholipase D by phosphoinositides | Sciorra et al. 1047
that is mediated by the polybasic domain is highly specific
for PI(4,5)P2, our results suggest a more general role for this
motif in anchoring the protein to membrane surfaces con-
taining acidic lipids. Future work on the three-dimensional
structure of the catalytic core of PLD that includes this poly-
basic domain should give insight into how this domain in-
teracts with acidic phospholipids yet confers selectivity for
stimulation of catalysis by PI(4,5)P2.
PLD activity has been associated with a very wide range of
cellular functions, and this complexity has, for the most
part, been ascribed to the complex and isoenzyme-specific
regulation of the enzymes by both posttranslational modifi-
cations and actions of protein and lipid regulators. Our
studies suggest that differential targeting of PLD to intra-
cellular membrane compartments is an equally important
determinant of PLD function in yeast and mammalian
cells. The work presented here identifies the NH2-terminal
PH domain as an important component of this process
and shows that this domain confers selective targeting to
PI(4,5)P2-rich membranes through a weak, but selective, in-
teraction with this lipid that operates in conjunction with a
higher affinity, but less selective, membrane interaction me-
diated by the polybasic motif.
Materials and methods
General reagents
Unless otherwise stated, reagents used in this study were of analytical grade.
The sources of general reagents used in this study can be found in prior pub-
lications (Sciorra and Morris, 1999; Sciorra et al., 1999, 2001). Phospholip-
ids used in this study were purchased from Avanti Polar Lipids, Inc. The am-
monium salt of PI(4,5)P2 was either purchased from Avanti Polar Lipids, Inc.
or Roche Molecular Biochemicals or purified from bovine brain extract
(Sigma-Aldrich) as described elsewhere (Sciorra et al., 1999). (dioleoyl-
1-
14C)-L- -dioleoyl-PC and (ethyl-1,2-
3H)-N-ethyl-maleimide were from Per-
kinElmer. Non-radioactive N-ethyl-maleimide (NEM) was from Sigma-Aldrich.
[
3H]choline-labeled 1-palmitoyl-2-oleoyl-sn-glycero-3-PC and [
3H]oleic and
palmitic acids were from American Radiolabeled Chemicals.
Protein expression and purification
Wild-type and mutant PLD1 and PLD2 were expressed in insect cells using
recombinant baculoviruses, purified to homogeneity by immunoaffinity
chromatography, and quantitated as described previously (Sciorra et al.,
1999). The PLD2 mutants were generated using the Quick Change proto-
col (Stratagene) and confirmed by sequencing and/or restriction digestion.
The PH domain from PLD2, which encompassed F196–R315, was ampli-
fied by PCR using primer adaptors and used to construct a baculovirus
vector for expression of this protein with an NH2-terminal glu-glu tag to fa-
cilitate purification by affinity chromatography (Sciorra et al., 1999). The
purified proteins were stored at 4 C and used within 2 d of preparation.
PLD activators including ADP ribosylation factor and Rho family GTP-
binding proteins were expressed and purified as described in Hammond et
al. (1997). Recombinant human PLC- 1 was purified from Escherichia coli
as described in Tall et al. (1997).
Peptide synthesis and labeling
The sequence of murine PLD2(554–575) is RDLARHFIQRWNFTKTT-
KARYK. Two peptides corresponding to this region were obtained from
American Peptide Company, Inc. One has an extra Cys at its NH2 terminus
for labeling with [
3H]NEM. The other lacks the Cys and was used in the
PLC assay. Both peptides are blocked with acetyl at their NH2-terminal and
amide at their COOH-terminal regions. The PLD2(554–575) peptide was
covalently labeled with a radioactive [
3H]NEM to the NH2-terminal Cys
and purified by HPLC (Wang et al., 2002).
Vesicle preparations
Sucrose-loaded LUVs were prepared as described in Buser and McLaugh-
lin (1998). In brief, the desired lipid mixture was dried on a rotary evapora-
tor and then hydrated in a solution containing 176 mM sucrose, 1 mM
MOPS, pH 7.0. The lipid mixture underwent five cycles of freezing and
thawing and then was passed through a stack of two polycarbonate filters
(0.1-mm diameter pore size) using a Lipex Biomembranes extruder or, in
some cases, using a syringe mini extruder from Avanti Polar Lipids, Inc. for
10 cycles. The buffer was then exchanged with 100 mM KCl, 1 mM
MOPS, pH 7.0.
Centrifugation binding measurements
The binding of [
3H]NEM-labeled PLD2(554–575) peptide to sucrose-
loaded PC/PI(4,5)P2 (99:1) LUVs or PC/PS (5:1) LUVs was measured using
a centrifugation technique described in Buser and McLaughlin (1998). In
brief, sucrose-loaded LUVs were mixed with [
3H]NEM-labeled PLD pep-
tide or PLD protein and centrifuged at 100,000 g for 1 h. The radioactivity
of the supernatant and the pellet was measured to determine the percent-
age of peptide bound. In experiments using wild type and mutant PLD pro-
teins of the PLD2 PH domain, the above procedure was adapted as de-
scribed in Sciorra et al. (1999) and PLD binding was quantitated by
making measurements of PLD activity remaining in the supernatant or by
analyzing supernatant and lipid pellet fractions by SDS-PAGE and Western
blotting. In the case of the PLD2 PH domain, we used a monoclonal anti-
body (1H10) that recognizes the appended glu-glu epitope (Sciorra et al.,
2001).
Peptide binding calculations
We use a molar partition coefficient K to describe the binding of the pep-
tide to lipid vesicles without making assumptions about the absorption
mechanism. The molar partition coefficient K is defined in the equation
[P]m/[L]   K[P], where [P]m is the molar concentration of peptide parti-
tioned to the membrane, [P] is the molar concentration of free peptide in
the bulk aqueous phase, and [L] is the molar concentration of lipid accessi-
ble to the peptide. Under our conditions, [L]    [P]m. Thus [L] does not
change significantly after the peptide binds and is   0.5 of the total lipid
concentration for these LUVs because the peptide interacts only with the
outer leaflet of the bilayer; the vesicles are not permeable to the peptide,
which is added to a solution of preformed vesicles. Combining the defini-
tion of K with the equation [P]tot   [P]m   [P], we get Equation 1:
(1)
PLC assay in a monolayer system
The effect of the PLD2(554–575) peptide on the PLC-catalyzed hydrolysis
of PI(4,5)P2 in a monolayer system as described elsewhere (Wang et al.,
2002). In brief, we deposited  60  l of a lipid stock in chloroform, which
contains 55  M PC/[
3H]PI(4,5)P2 (66:33:1), onto the surface of a 15-ml so-
lution in a 5-cm-diameter Teflon trough. The subphase solution contained
100 mM KCl, 25 mM Hepes, 0.1 mM EGTA, 1 mM DTT, pH 7.0. Once the
chloroform had evaporated (10 min), we measured the surface pressure of
the monolayer (typically 25 mN/m) using a square piece of filter paper and
a balance as described previously (Boguslavsky et al., 1994). We then
added PLD peptide to the subphase. After 3 min, we added PLC- 1 (final
concentration  0.1 nM). After another 3 min, we added 100 mM CaCl2 to
the subphase to produce a free concentration of Ca 
2  ( 2 mM) that pro-
duces significant activation of PLC- . We collected 200- l aliquots of the
subphase at different times after the addition of Ca
2  and measured the ra-
dioactivity due to [
3H]inositol 1,4,5-trisphosphate (Boguslavsky et al.,
1994).
PLD activity assays
Activity of wild-type and mutant PLD isoenzymes was measured in vitro
using [
3H]PC presented in sonicated lipid dispersions containing PE and, in
some cases, varying concentrations of PI(4,5)P2. Where indicated, activity
was also determined using BODIPY-PC as substrate, as described in Rudge
et al. (1998a) and Sciorra and Morris (1999). Measurements of PLD activity
in intact cells were performed by prelabeling the cells with [
3H]palmitic
acid overnight, treating the cells with 0.3% butanol, and measuring PLD-
catalyzed formation of phosphatidylbutanol by extraction and TLC analy-
sis of total cellular lipids as described in Sciorra et al. (1999).
Mammalian expression plasmids
Vectors for expression of PLD1 and PLD2 as NH2-terminal fusions with
EGFP have been described previously (Sung et al., 1999b), and these were
used as templates for site-directed mutagenesis as described above. The
vector for expression of the GFP-tagged PLD2 PH domain was made using
the PCR strategy described above for insect cell expression of the protein
P [] m
P [] tot
--------------- KL []
1 KL [] +
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to generate a cDNA fragment that was inserted into the pEGFP vector.
Mammalian cell transfections were done using lipofectamine (Invitrogen).
Confocal fluorescence microscopy
Cells were cultured on poly-L-lysine–coated glass coverslips and transfected
with corresponding plasmids as described in Sciorra and Morris, 1999.
Cells were fixed with 4% paraformaldehyde in PBS and then mounted in
prolong antifade reagent (Molecular Probes) before analysis by confocal flu-
orescence microscopy using a Nikon Eclipse PCM system or a ZEISS 410
confocal laser scanning microscope. Images were processed using software
provided by the manufacturers and edited with Adobe Photoshop
®.
Cell fractionation
HEK293 cells transfected with vectors for expression of wild-type and mu-
tant PLD2 were harvested and fractionated into soluble and total particu-
late fractions by ultracentrifugation at 100,000 g as described in Sciorra et
al. (1999). Detergent-resistant membrane fractions were isolated from
HEK293 cells that had been transfected with vectors for expression of
PLD2 by extraction in 1% Triton X-100 followed by sucrose density gradi-
ent fractionation. Fractions were collected from the top of the gradient and
analyzed for PLD2 protein by SDS-PAGE and Western blotting (Sciorra
and Morris, 1999).
Yeast strains
Genotypes of yeast strains are listed in Table I. Yeast manipulations were
performed and media were prepared using standard procedures. Yeast
transformations were performed by the lithium acetate procedure. Cells
were initiated to sporulate in 2% potassium acetate after transfer from syn-
thetic complete medium without uracil (SC-ura). Sporulation frequencies
were determined after 48 h by examining a minimum of 600 cells (Rudge
et al., 1998a,b, 2001).
Yeast plasmids
GFP–Spo14p and HA–Spo14p have been reported previously (Rudge et al.,
1998a,b). The K533E mutation was generated by site-directed mutagenesis as
described using plasmids ME986 and ME1095 as templates for the mutagen-
esis (Sciorra et al., 1999) to generate pME1765 (HA–spo14K533E URA3
CEN4) and pME1767 (GFP–spo14 K533E URA3 2 ).
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